Cargando…

The gut-retina axis: a new perspective in the prevention and treatment of diabetic retinopathy

Diabetic retinopathy (DR) is a microvascular lesion that occurs as a complication of diabetes mellitus. Many studies reveal that retinal neurodegeneration occurs early in its pathogenesis, and abnormal retinal function can occur in patients without any signs of microvascular abnormalities. The gut m...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Haiyan, Mo, Ya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352852/
https://www.ncbi.nlm.nih.gov/pubmed/37469982
http://dx.doi.org/10.3389/fendo.2023.1205846
_version_ 1785074599458766848
author Zhang, Haiyan
Mo, Ya
author_facet Zhang, Haiyan
Mo, Ya
author_sort Zhang, Haiyan
collection PubMed
description Diabetic retinopathy (DR) is a microvascular lesion that occurs as a complication of diabetes mellitus. Many studies reveal that retinal neurodegeneration occurs early in its pathogenesis, and abnormal retinal function can occur in patients without any signs of microvascular abnormalities. The gut microbiota is a large, diverse colony of microorganisms that colonize the human intestine. Studies indicated that the gut microbiota is involved in the pathophysiological processes of DR and plays an important role in its development. On the one hand, numerous studies demonstrated the involvement of gut microbiota in retinal neurodegeneration. On the other hand, alterations in gut bacteria in RD patients can cause or exacerbate DR. The present review aims to underline the critical relationship between gut microbiota and DR. After a brief overview of the composition, function, and essential role of the gut microbiota in ocular health, and the review explores the concept of the gut-retina axis and the conditions of the gut-retina axis crosstalk. Because gut dysbiosis has been associated with DR, the review intends to determine changes in the gut microbiome in DR, the hypothesized mechanisms linking to the gut-retina axis, and its predictive potential.
format Online
Article
Text
id pubmed-10352852
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-103528522023-07-19 The gut-retina axis: a new perspective in the prevention and treatment of diabetic retinopathy Zhang, Haiyan Mo, Ya Front Endocrinol (Lausanne) Endocrinology Diabetic retinopathy (DR) is a microvascular lesion that occurs as a complication of diabetes mellitus. Many studies reveal that retinal neurodegeneration occurs early in its pathogenesis, and abnormal retinal function can occur in patients without any signs of microvascular abnormalities. The gut microbiota is a large, diverse colony of microorganisms that colonize the human intestine. Studies indicated that the gut microbiota is involved in the pathophysiological processes of DR and plays an important role in its development. On the one hand, numerous studies demonstrated the involvement of gut microbiota in retinal neurodegeneration. On the other hand, alterations in gut bacteria in RD patients can cause or exacerbate DR. The present review aims to underline the critical relationship between gut microbiota and DR. After a brief overview of the composition, function, and essential role of the gut microbiota in ocular health, and the review explores the concept of the gut-retina axis and the conditions of the gut-retina axis crosstalk. Because gut dysbiosis has been associated with DR, the review intends to determine changes in the gut microbiome in DR, the hypothesized mechanisms linking to the gut-retina axis, and its predictive potential. Frontiers Media S.A. 2023-07-04 /pmc/articles/PMC10352852/ /pubmed/37469982 http://dx.doi.org/10.3389/fendo.2023.1205846 Text en Copyright © 2023 Zhang and Mo https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Zhang, Haiyan
Mo, Ya
The gut-retina axis: a new perspective in the prevention and treatment of diabetic retinopathy
title The gut-retina axis: a new perspective in the prevention and treatment of diabetic retinopathy
title_full The gut-retina axis: a new perspective in the prevention and treatment of diabetic retinopathy
title_fullStr The gut-retina axis: a new perspective in the prevention and treatment of diabetic retinopathy
title_full_unstemmed The gut-retina axis: a new perspective in the prevention and treatment of diabetic retinopathy
title_short The gut-retina axis: a new perspective in the prevention and treatment of diabetic retinopathy
title_sort gut-retina axis: a new perspective in the prevention and treatment of diabetic retinopathy
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352852/
https://www.ncbi.nlm.nih.gov/pubmed/37469982
http://dx.doi.org/10.3389/fendo.2023.1205846
work_keys_str_mv AT zhanghaiyan thegutretinaaxisanewperspectiveinthepreventionandtreatmentofdiabeticretinopathy
AT moya thegutretinaaxisanewperspectiveinthepreventionandtreatmentofdiabeticretinopathy
AT zhanghaiyan gutretinaaxisanewperspectiveinthepreventionandtreatmentofdiabeticretinopathy
AT moya gutretinaaxisanewperspectiveinthepreventionandtreatmentofdiabeticretinopathy